4basebio DNA enters the clinic for mRNA production! We are delighted to announce that 4basebio's synthetic, enzymatically produced opDNA(TM) has been used in the production of HelixNano's HN-0001, a next-generation COVID19 mRNA vaccine candidate. Human Research Ethics Committee (HREC) has approved a Phase 1 clinical trial, with participants anticipated to be dosed in April 2024. HN-0001 is specifically designed to prevent COVID-19 in immunosuppressed and immunocompromised populations. Read the full press release here -https://lnkd.in/eYZDqZZj
HelixNano
Biotechnology Research
Cambridge, Massachusetts 1,160 followers
Building the world's most advanced mRNA platform to solve civilizational problems from covid to climate.
About us
HelixNano is building the world's most advanced mRNA platform to enable previously impossible applications across human and non-human biology
- Website
-
http://helixnano.com
External link for HelixNano
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2013
Locations
-
Primary
700 Main St
Cambridge, Massachusetts 02139, US
Employees at HelixNano
-
Cassandra Murray
Keeping you organized and getting your employees hyped on the culture.
-
Alon Brandman
Founding Partner @ Raspberry Ventures // Investing in companies developing groundbreaking technologies.
-
Nikolai Radzinski
Metagenomic Navigator at HelixNano
-
Nicole Camfield (Brellenthin)
Head of Operations at HelixNano
Updates
-
George Church, Professor of Genetics at Harvard Medical School and the chair of HelixNano's scientific advisory board, commented: “HelixNano has built a deep stack of mRNA technologies to interface with immune cells with unprecedented precision. HREC approval to begin a Phase 1 trial marks the point where they can start bringing the benefits of this exciting work from the lab to patients. The immune system is our most powerful weapon against nearly all disease, including cancer and aging, and we can now augment it when it struggles.” Congratulations on reaching this HUGE milestone, Hannu, Nikolai, Carina, and team! #startups #venturecapital #innovation